Here's Why CRISPR Stocks Fell as Much as 40.7% in October

Here's Why CRISPR Stocks Fell as Much as 40.7% in October

Source: 
Motley Fool
snippet: 

Shares of the three leading CRISPR gene-editing stocks dropped between 20% and 41% last month according to data provided by S&P Global Market Intelligence. Nearly the entire stock market took a breather in October, which helped to adjust its historically expensive valuation -- well, a tiny bit anyway.